This compound is a pharmaceutical intermediate featuring an azetidine ring with a hydroxymethyl substituent and a tert-butoxycarbonyl protecting group. It is primarily used in the synthesis of active pharmaceutical ingredients.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 142253-56-3
2,6-Heptadienoic acid, 7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-5-hydroxy-, (2Z,5S,6E)-
Pharmaceutical intermediate for drug synthesis
6-~{tert}-Butyl-8-Fluoranyl-2-[3-(Hydroxymethyl)-4-[1-Methyl-5-[[5-(1-Methylpiperidin-4-Yl)pyridin-2-Yl]amino]-6-Oxidanylidene-Pyridazin-3-Yl]pyridin-2-Yl]phthalazin-1-One
BTK inhibitor intermediate
((((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)(ethoxy)phosphoryl)oxy)methyl pivalate
prodrug intermediate for adefovir
Tert-Butyl (6-bromohexyl)carbamate
building block for pharmaceutical synthesis
Tert-butyl 3-hydroxyazetidine-1-carboxylate
protected building block for synthesis
Tert-butyl 3-iodoazetidine-1-carboxylate
Pharmaceutical intermediate for synthesis
3-Methoxyazetidine hydrochloride
Research reagent
1-[(tert-butoxy)carbonyl]azetidine-2-carboxylic acid
Pharmaceutical intermediate for peptide synthesis
tert-butyl 3-(hydroxymethyl)azetidine-1-carboxylate
HXRDRJKAEYHOBB-UHFFFAOYSA-N
CC(C)(C)OC(=O)N1CC(C1)CO